Personal information

No personal information available

Activities

Collapse all

Employment (1)

Uniklinikum Salzburg - Christian-Doppler-Klinik: Salzburg, Salzburg, AT

Head of the Multiple Sclerosis Outpatient Clinic (Neurology)
Employment
Source: Self-asserted source
Peter Wipfler

Works (47)

Intrathecal Immunoglobulin A Synthesis in Multiple Sclerosis: From Biological Aspects to Clinical Relevance

Biomolecules
2025-01-11 | Journal article
DOI: 10.3390/biom15010108
Contributors: Dariia Kliushnikova; Ferdinand Otto; Georg Pilz; Peter Wipfler; Andrea Harrer
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Cerebrospinal Fluid Cytology in Lyme Neuroborreliosis Revisited—Role of Neutrophilic Granulocytes: A Retrospective Single-Center Study

Journal of Clinical Medicine
2024-12-05 | Journal article
DOI: 10.3390/jcm13237406
Contributors: Ferdinand Otto; Peter Wipfler; Wolfgang Hitzl; Martin Preisel; Andrea Harrer; Georg Pilz
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study

International Journal of Molecular Sciences
2023-03 | Journal article | Author
DOI: 10.3390/ijms24076552
Contributors: Fabian Foettinger; Georg Pilz; Peter Wipfler; Andrea Harrer; Jan Marco Kern; Eugen Trinka; Tobias Moser
Source: check_circle
Multidisciplinary Digital Publishing Institute

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting

International Journal of Molecular Sciences
2023-02-17 | Journal article
DOI: 10.3390/ijms24044067
Contributors: Michael Seiberl; Julia Feige; Patrick Hilpold; Wolfgang Hitzl; Lukas Machegger; Arabella Buchmann; Michael Khalil; Eugen Trinka; Andrea Harrer; Peter Wipfler et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery

Neurology International
2022-11 | Journal article | Author
DOI: 10.3390/neurolint14040075
Contributors: Julia Feige; Klaus Berek; Michael Seiberl; Patrick Hilpold; Wolfgang Hitzl; Franziska Di Pauli; Harald Hegen; Florian Deisenhammer; Eugen Trinka; Andrea Harrer et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak

International Journal of Molecular Sciences
2022-10 | Journal article | Author
DOI: 10.3390/ijms231911632
Contributors: Eirini Mylonaki; Michael Seiberl; Neil Jones; Heike Bernhard; Ferdinand Otto; Georg Pilz; Eugen Trinka; Peter Wipfler
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Impact of vaccination on COVID-19 outcome in multiple sclerosis.

European journal of neurology
2022-07 | Journal article
DOI: 10.1111/ene.15488
PMID: 35791496
Contributors: Bsteh G; Gradl C; Heschl B; Hegen H; Di Pauli F; Assar H; Leutmezer F; Traxler G; Krajnc N; Zulehner G et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.

European journal of neurology
2022-06 | Journal article
DOI: 10.1111/ene.15477
PMID: 35751475
Contributors: Bsteh G; Assar H; Gradl C; Heschl B; Hiller MS; Krajnc N; Di Pauli F; Hegen H; Traxler G; Leutmezer F et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.

Therapeutic advances in neurological disorders
2022-04 | Journal article
DOI: 10.1177/17562864221092092
PMID: 35479655
PMC: PMC9036387
Contributors: Moser T; O'Sullivan C; Otto F; Hitzl W; Pilz G; Schwenker K; Mrazek C; Haschke-Becher E; Trinka E; Wipfler P et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events

Journal of Neurology
2022-02 | Journal article
DOI: 10.1007/s00415-021-10707-2
Contributors: C. O´Sullivan; F. Zach; T. Moser; G. Pilz; A. Harrer; E. Trinka; C. Enzinger; J. A. R. Pfaff; P. Wipfler
Source: check_circle
Crossref

Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.

Multiple sclerosis and related disorders
2022-01 | Journal article
DOI: 10.1016/j.msard.2022.103560
PMID: 35093840
PMC: PMC8785406
Contributors: Moser T; Otto F; O'Sullivan C; Hitzl W; Pilz G; Harrer A; Trinka E; Wipfler P
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities.

Diagnostics (Basel, Switzerland)
2021-12 | Journal article
DOI: 10.3390/diagnostics12010079
PMID: 35054246
PMC: PMC8774636
Contributors: Otto F; Harrer C; Pilz G; Wipfler P; Harrer A
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.

Multiple sclerosis (Houndmills, Basingstoke, England)
2021-10 | Journal article
DOI: 10.1177/13524585211049391
PMID: 34595968
PMC: PMC8597187
Contributors: Bsteh G; Dürauer S; Assar H; Hegen H; Heschl B; Leutmezer F; Pauli FD; Gradl C; Traxler G; Zulehner G et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.

Biomedicines
2021-10 | Journal article
DOI: 10.3390/biomedicines9111584
PMID: 34829815
PMC: PMC8615381
Contributors: Moser T; O'Sullivan C; Puttinger C; Feige J; Pilz G; Haschke-Becher E; Cadamuro J; Oberkofler H; Hitzl W; Harrer A et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.

Frontiers in immunology
2021-08 | Journal article
DOI: 10.3389/fimmu.2021.718895
PMID: 34512642
PMC: PMC8428149
Contributors: Moser T; Seiberl M; Feige J; Bieler L; Radlberger RF; O'Sullivan C; Pilz G; Harrer A; Schwenker K; Haschke-Becher E et al.
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.

Fluids and barriers of the CNS
2021-08 | Journal article
DOI: 10.1186/s12987-021-00272-1
PMID: 34446066
PMC: PMC8390062
Contributors: Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
Source: Self-asserted source
Peter Wipfler via Europe PubMed Central

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.

PloS one
2021-07-27 | Journal article
DOI: 10.1371/journal.pone.0255316
PMID: 34314457
Source: Self-asserted source
Peter Wipfler

Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine.

Multiple sclerosis and related disorders
2020-12-29 | Journal article
DOI: 10.1016/j.msard.2020.102727
PMID: 33418308
Source: Self-asserted source
Peter Wipfler

Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
2020-03-30 | Journal article
DOI: 10.1016/j.jcv.2020.104340
PMID: 32302952
Source: Self-asserted source
Peter Wipfler

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.

Fluids and barriers of the CNS
2020-02-24 | Journal article
DOI: 10.1186/s12987-020-0170-5
PMID: 32089130
PMC: PMC7038591
Source: Self-asserted source
Peter Wipfler

Delayed high-grade atrioventricular block requiring pacemaker implantation in a multiple sclerosis patient treated with fingolimod.

Multiple sclerosis and related disorders
2019-11-09 | Journal article
DOI: 10.1016/j.msard.2019.101515
PMID: 31751857
Source: Self-asserted source
Peter Wipfler

Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.

Journal of neuroimmunology
2019-11-02 | Journal article
DOI: 10.1016/j.jneuroim.2019.577087
PMID: 31715459
Source: Self-asserted source
Peter Wipfler

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.

Journal of neuroinflammation
2019-01-19 | Journal article
DOI: 10.1186/s12974-019-1405-8
PMID: 30660201
PMC: PMC6339696
Source: Self-asserted source
Peter Wipfler

The Viral Hypothesis of Mesial Temporal Lobe Epilepsy - Is Human Herpes Virus-6 the Missing Link? A systematic review and meta-analysis.

Seizure
2017-11-24 | Journal article
DOI: 10.1016/j.seizure.2017.11.015
PMID: 29195226
Source: Self-asserted source
Peter Wipfler

Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration.

Journal of virology
2017-05-12 | Journal article
DOI: 10.1128/jvi.02105-16
PMID: 28298607
PMC: PMC5432873
Source: Self-asserted source
Peter Wipfler

Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome.

Journal of neurology
2017-02-22 | Journal article
DOI: 10.1007/s00415-017-8418-y
PMID: 28229242
Source: Self-asserted source
Peter Wipfler

From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

Clinical immunology (Orlando, Fla.)
2017-01-17 | Journal article
DOI: 10.1016/j.clim.2017.01.001
PMID: 28108364
Source: Self-asserted source
Peter Wipfler

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

The New England journal of medicine
2016-12-21 | Journal article
DOI: 10.1056/nejmoa1606468
PMID: 28002688
Source: Self-asserted source
Peter Wipfler

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

PloS one
2016-05-31 | Journal article
DOI: 10.1371/journal.pone.0155795
PMID: 27244560
PMC: PMC4887025
Source: Self-asserted source
Peter Wipfler

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

International journal of molecular sciences
2015-09-10 | Journal article
DOI: 10.3390/ijms160921832
PMID: 26378517
PMC: PMC4613283
Source: Self-asserted source
Peter Wipfler

High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

Clinical and experimental immunology
2015-04-27 | Journal article
DOI: 10.1111/cei.12590
PMID: 25603898
Source: Self-asserted source
Peter Wipfler

Tumefactive MS lesions under fingolimod: a case report and literature review.

Neurology
2013-10-04 | Journal article
DOI: 10.1212/01.wnl.0000435293.34351.11
PMID: 24097813
Source: Self-asserted source
Peter Wipfler

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

Clinical and experimental immunology
2013-09-01 | Journal article
DOI: 10.1111/cei.12125
PMID: 23611040
Source: Self-asserted source
Peter Wipfler

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

Acta neurologica Scandinavica
2013-08-30 | Journal article
DOI: 10.1111/ane.12182
PMID: 24032536
Source: Self-asserted source
Peter Wipfler

Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.

Journal of neurology
2012-08-09 | Journal article
DOI: 10.1007/s00415-012-6622-3
PMID: 22875099
Source: Self-asserted source
Peter Wipfler

Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea.

Cerebrovascular diseases (Basel, Switzerland)
2012-04-05 | Journal article
DOI: 10.1159/000336120
PMID: 22488018
Source: Self-asserted source
Peter Wipfler

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

PloS one
2012-02-20 | Journal article
DOI: 10.1371/journal.pone.0031784
PMID: 22363732
PMC: PMC3282779
Source: Self-asserted source
Peter Wipfler

Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.

Acta neurologica Scandinavica
2011-12-26 | Journal article
DOI: 10.1111/j.1600-0404.2011.01630.x
PMID: 22211863
Source: Self-asserted source
Peter Wipfler

Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.

Multiple sclerosis (Houndmills, Basingstoke, England)
2011-09-30 | Journal article
DOI: 10.1177/1352458511423650
PMID: 21965415
Source: Self-asserted source
Peter Wipfler

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.

Journal of neuroimmunology
2011-03-29 | Journal article
DOI: 10.1016/j.jneuroim.2011.03.001
PMID: 21450349
Source: Self-asserted source
Peter Wipfler

Acute pulmonary edema caused by a multiple sclerosis relapse.

Journal of neurology
2011-02-01 | Journal article
DOI: 10.1007/s00415-011-5903-6
PMID: 21286744
Source: Self-asserted source
Peter Wipfler

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.

Drug discovery today
2010-11-03 | Journal article
DOI: 10.1016/j.drudis.2010.10.011
PMID: 21055477
Source: Self-asserted source
Peter Wipfler

Relationship between thrombin generation and carotid intima-media thickness.

Hamostaseologie
2010-11-01 | Journal article
PMID: 21042684
Source: Self-asserted source
Peter Wipfler

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.

Multiple sclerosis (Houndmills, Basingstoke, England)
2010-10-11 | Journal article
DOI: 10.1177/1352458510383075
PMID: 20937631
Source: Self-asserted source
Peter Wipfler

Invasive aspergillosis presenting with a painless complete ophthalmoplegia.

Clinical neurology and neurosurgery
2009-11-11 | Journal article
DOI: 10.1016/j.clineuro.2009.10.012
PMID: 19910107
Source: Self-asserted source
Peter Wipfler

Klebsiella meningoencephalitis presenting like embolic ischemic stroke.

Journal of neurology
2008-12-01 | Journal article
DOI: 10.1007/s00415-009-0046-8
PMID: 19153636
Source: Self-asserted source
Peter Wipfler

Modern multiple sclerosis treatment - what is approved, what is on the horizon.

Drug discovery today
2008-09-25 | Journal article
DOI: 10.1016/j.drudis.2008.08.003
PMID: 18775508
Source: Self-asserted source
Peter Wipfler

Peer review (1 review for 1 publication/grant)

Review activity for Wiener medizinische Wochenschrift. (1)
How many people are using ORCID?